- What are the top holdings of FMEDX?
- A machine-readable holdings disclosure for Fidelity Disruptive Medicine Fund (FMEDX) is not available from our data sources — fund families sometimes register portfolio filings under a sibling share class or outside the SEC's structured datasets. Rather than estimate, we leave the section blank; the issuer's website carries the authoritative portfolio list.
- What sectors does FMEDX invest in?
- Fidelity Disruptive Medicine Fund (FMEDX) allocates across the sectors shown above. The largest exposure tops the list; the rest follow in descending weight order.
- What sector is FMEDX most exposed to?
- FMEDX's full sector breakdown is on the Sectors tab. The largest sector weight is shown there along with the rest of the allocation.
- Is FMEDX a US-only fund?
- The country allocation card on this page shows FMEDX's geographic exposure. Funds with > 95% US weight are effectively US-only; international or global funds will show meaningful weights across multiple countries.
- What does FMEDX invest in?
- The fund primarily directs at least 80% of its total assets into companies that are leading advancements in the medical sector. Its core investments largely consist of equity instruments. According to the Adviser, "disruptive medicine" companies encompass, but are not limited to, those engaged in fields such as robotic surgical procedures, gene therapy, genomic research, treatments for rare conditions, cutting-edge medical devices and apparatus, immunotherapy, digital healthcare platforms, and initiatives promoting consumer well-being. It is important to note that this fund operates as a non-diversified portfolio.
